Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the Asthma Therapeutics Market Expected to Be in 2029?

The market size of asthma therapeutics has witnessed robust growth lately. The sector, which was valued at $30.63 billion in 2024, is projected to reach $33.11 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.1%. This growth during the historic phase has been propelled by an enhanced understanding of asthma management, wider usage of inhalers and nebulizers, an increased incidence of allergic asthma due to pollution, government actions prioritizing respiratory health, and a developing healthcare infrastructure in burgeoning economies.

The market size of asthma therapeutics is predicted to witness substantial expansion in the approaching years. The market is set to rise to $44.53 billion by 2029, with a compound annual growth rate (CAGR) of 7.7%. This projected growth over the forecast period can be linked to a surge in demand for biologics in the treatment of asthma, an escalating emphasis on personalized medicine, a growing adoption of smart health devices and digital inhalers, an increase in cases of pediatric asthma, and heightened investment in the research and development of innovative therapeutics. Key trends over the forecast period are expected to be the progress in biologic treatments for severe asthma, the evolution of inhaler technologies with digital tracking capabilities, the development of personalized asthma management plans, advancements in drug delivery systems, and the incorporation of artificial intelligence and wearable tech in the monitoring of asthma.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25702&type=smp

What Are The Contributors To Demand In The Asthma Therapeutics Market?

The surge in asthma cases is projected to fuel the expansion of the asthma therapeutics market. Asthma is a chronic illness characterized by inflammation and swelling of the air passage, leading to the constricting of airways that transport air from the nose and mouth to the lungs. The rise in asthma cases can be attributed to escalating pollutants that agitate the airways, increasing the likelihood of contracting the condition. Asthma therapeutics aim to manage asthma by alleviating symptoms, controlling airway inflammation, and averting asthma attacks. Inhaled corticosteroids, which are long-term control medicines, minimize chronic inflammation, while immediate relief is provided by quick-relief medications like bronchodilators during flare-ups. Asthma + Lung UK, a charity based in England that advocates for individuals with lung conditions, reported that asthma-related fatalities in England rose from 1,146 in 2021 to 1,236 in 2022 in April 2024. Consequently, the escalating cases of asthma are propelling the expansion of the asthma therapeutics market.

What Segmentation Categories Are Included In The Asthma Therapeutics Market Analysis?

The asthma therapeutics market covered in this report is segmented –

1) By Drug Class: Inhaled Corticosteroids (ICS), Long-Acting Beta Agonists (LABA), Leukotriene Receptor Antagonists (LTRA), Short-Acting Beta Agonists (SABA), Biologics, Combination Inhalers (ICS + LABA)

2) By Treatment Stage: Acute Treatment, Long-Term Control, Preventive Treatment, Maintenance Regimens, Rescue Medications

3) By Route Of administration: Oral, Inhaled, Intravenous, Subcutaneous

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End-User: Hospitals, Homecare, Specialty Clinics

Subsegments:

1) By Inhaled Corticosteroids (ICS): Fluticasone, Budesonide, Beclomethasone, Mometasone, Ciclesonide

2) By Long-Acting Beta Agonists (LABA): Salmeterol, Formoterol, Indacaterol, Olodaterol

3) By Leukotriene Receptor Antagonists (LTRA): Montelukast, Zafirlukast, Pranlukast

4) By Short-Acting Beta Agonists (SABA): Albuterol (Salbutamol), Levalbuterol, Terbutaline

5) By Biologics: Omalizumab, Mepolizumab, Benralizumab, Dupilumab, Reslizumab

6) By Combination Inhalers (ICS + LABA): Fluticasone + Salmeterol, Budesonide + Formoterol, Mometasone + Indacaterol, Beclomethasone + Formoterol

What Upcoming Trends Are Expected To Impact The Asthma Therapeutics Market Globally?

Leading businesses in the asthma therapeutics market are striving to pioneer novel products like fixed-dose combination (FDC) drugs to bolster treatment effectiveness and elevate patient compliance. An FDC drug integrates two or more active medicinal ingredients into a single dose form, such as an inhaler or tablet, designed to address a specific ailment. Take for example, in June 2022, India’s Glenmark Pharmaceuticals Limited introduced a new FDC drug, Indacaterol plus Mometasone, intended for the treatment of asthma. Indacaterol functions as a long-acting beta-agonist (LABA) that relaxes the muscles in the airways, while Mometasone serves as an inhaled corticosteroid (ICS) that mitigates lung inflammation. This FDC is meant to provide enhanced symptoms management and convenience with daily single dosing, thereby improving treatment observance among patients suffering from moderate to severe asthma.

Who Are The Top-Ranked Companies In The Asthma Therapeutics Market Today?

Major companies operating in the asthma therapeutics market are Roche Holding AG, Merck & Co Inc., Pfizer Inc., AstraZeneca plc, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Vertex Pharmaceuticals Incorporated, Sun Pharmaceutical Industries Ltd., Chiesi Farmaceutici S.p.A., Cipla Limited, Mundipharma International Limited, ALK-Abello, Mylan N.V., Whanin Pharmaceutical, Mitsubishi Tanabe Pharma, Allergan plc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/asthma-therapeutics-global-market-report

How Is Asthma Therapeutics Market Adoption Varying Across Different Regions And Sectors?

North America was the largest region in the asthma therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=25702&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model